Ideaya Biosciences Stock Analysis

IDYA Stock  USD 27.45  0.09  0.33%   
Ideaya Biosciences is undervalued with Real Value of 29.57 and Target Price of 36.08. The main objective of Ideaya Biosciences stock analysis is to determine its intrinsic value, which is an estimate of what Ideaya Biosciences is worth, separate from its market price. There are two main types of Ideaya Biosciences' stock analysis: fundamental analysis and technical analysis.
The Ideaya Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ideaya Biosciences' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ideaya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.

Ideaya Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of Ideaya Biosciences was currently reported as 13.67. The company recorded a loss per share of 2.33. Ideaya Biosciences had not issued any dividends in recent years. IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Ideaya Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 91 people. To learn more about Ideaya Biosciences call the company at 650 443 6209 or check out https://www.ideayabio.com.

Ideaya Biosciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ideaya Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ideaya Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ideaya Biosciences generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 23.39 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (38.6 M).
Ideaya Biosciences currently holds about 268.62 M in cash with (115.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.83.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: IDEAYA Biosciences Announces Participation in Upcoming December 2024 Investor Relations Events

Ideaya Biosciences Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ideaya Biosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
5th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Ideaya Largest EPS Surprises

Earnings surprises can significantly impact Ideaya Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-20
2023-12-31-0.47-0.52-0.0510 
2022-05-10
2022-03-31-0.41-0.360.0512 
2023-08-10
2023-06-30-0.56-0.50.0610 
View All Earnings Estimates

Ideaya Biosciences Environmental, Social, and Governance (ESG) Scores

Ideaya Biosciences' ESG score is a quantitative measure that evaluates Ideaya Biosciences' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Ideaya Biosciences' operations that may have significant financial implications and affect Ideaya Biosciences' stock price as well as guide investors towards more socially responsible investments.

Ideaya Stock Institutional Investors

Shares
Geode Capital Management, Llc2024-09-30
1.9 M
Pictet Asset Manangement Sa2024-09-30
1.9 M
Sofinnova Ventures2024-09-30
1.7 M
Bvf Inc2024-09-30
1.4 M
Avidity Partners Management Lp2024-09-30
1.4 M
Ra Capital Management, Llc2024-09-30
1.3 M
Fiera Capital Corporation2024-06-30
1.3 M
Baker Bros Advisors Lp2024-09-30
1.1 M
Citadel Advisors Llc2024-09-30
1.1 M
Fmr Inc2024-09-30
12.6 M
Blackrock Inc2024-06-30
6.8 M
Note, although Ideaya Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ideaya Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.37 B.

Ideaya Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.17)(0.18)
Return On Capital Employed(0.22)(0.23)
Return On Assets(0.17)(0.18)
Return On Equity(0.18)(0.17)

Management Efficiency

Ideaya Biosciences has return on total asset (ROA) of (0.1585) % which means that it has lost $0.1585 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.211) %, meaning that it created substantial loss on money invested by shareholders. Ideaya Biosciences' management efficiency ratios could be used to measure how well Ideaya Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of December 3, 2024, Return On Tangible Assets is expected to decline to -0.18. In addition to that, Return On Capital Employed is expected to decline to -0.23. At present, Ideaya Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 422 M, whereas Non Currrent Assets Other are forecasted to decline to about 416.2 K.
Last ReportedProjected for Next Year
Book Value Per Share 9.72  10.20 
Tangible Book Value Per Share 9.72  10.20 
Enterprise Value Over EBITDA(14.51)(15.24)
Price Book Value Ratio 3.30  3.46 
Enterprise Value Multiple(14.51)(15.24)
Price Fair Value 3.30  3.46 
Enterprise Value1.9 BB
The strategic vision of Ideaya Biosciences management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Operating Margin
(57.31)
Beta
0.858
Return On Assets
(0.16)
Return On Equity
(0.21)

Technical Drivers

As of the 3rd of December, Ideaya Biosciences retains the Market Risk Adjusted Performance of (0.31), standard deviation of 2.89, and Risk Adjusted Performance of (0.12). Ideaya Biosciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Ideaya Biosciences Price Movement Analysis

Execute Study
The output start index for this execution was twenty-seven with a total number of output elements of thirty-four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ideaya Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ideaya Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Ideaya Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ideaya Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ideaya Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ideaya Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ideaya Biosciences Outstanding Bonds

Ideaya Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ideaya Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ideaya bonds can be classified according to their maturity, which is the date when Ideaya Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Ideaya Biosciences Predictive Daily Indicators

Ideaya Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ideaya Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ideaya Biosciences Corporate Filings

13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
12th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
4th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
25th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
4th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
27th of September 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
23rd of September 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
6th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Ideaya Biosciences Forecast Models

Ideaya Biosciences' time-series forecasting models are one of many Ideaya Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ideaya Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Ideaya Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ideaya Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ideaya shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ideaya Biosciences. By using and applying Ideaya Stock analysis, traders can create a robust methodology for identifying Ideaya entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(4.83)(5.07)
Operating Profit Margin(5.75)(6.04)
Net Loss(4.83)(5.07)
Gross Profit Margin 0.83  0.87 

Current Ideaya Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ideaya analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ideaya analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
36.08Strong Buy14Odds
Ideaya Biosciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Ideaya analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ideaya stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ideaya Biosciences, talking to its executives and customers, or listening to Ideaya conference calls.
Ideaya Analyst Advice Details

Ideaya Stock Analysis Indicators

Ideaya Biosciences stock analysis indicators help investors evaluate how Ideaya Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ideaya Biosciences shares will generate the highest return on investment. By understating and applying Ideaya Biosciences stock analysis, traders can identify Ideaya Biosciences position entry and exit signals to maximize returns.
Begin Period Cash Flow68.7 M
Common Stock Shares Outstanding57.5 M
Total Stockholder Equity621.1 M
Property Plant And Equipment Net8.4 M
Cash And Short Term Investments525.1 M
Cash157 M
Accounts Payable6.6 M
Net Debt-154.1 M
50 Day M A29.6864
Total Current Liabilities27.1 M
Other Operating Expenses157.8 M
Non Current Assets Total116.7 M
Forward Price Earnings4.649
Non Currrent Assets Other782 K
Stock Based Compensation18.5 M

Complementary Tools for Ideaya Stock analysis

When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Managers
Screen money managers from public funds and ETFs managed around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets